110 related articles for article (PubMed ID: 19574280)
1. Association study of AMP-activated protein kinase subunit genes in polycystic ovary syndrome.
Sproul K; Jones MR; Azziz R; Goodarzi MO
Eur J Endocrinol; 2009 Sep; 161(3):405-9. PubMed ID: 19574280
[TBL] [Abstract][Full Text] [Related]
2. Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome.
Goodarzi MO; Antoine HJ; Azziz R
J Clin Endocrinol Metab; 2007 Jul; 92(7):2659-64. PubMed ID: 17426092
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome.
Antoine HJ; Pall M; Trader BC; Chen YD; Azziz R; Goodarzi MO
Fertil Steril; 2007 Apr; 87(4):862-9. PubMed ID: 17141766
[TBL] [Abstract][Full Text] [Related]
4. Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome.
Xu N; Taylor KD; Azziz R; Goodarzi MO
Fertil Steril; 2010 Jun; 94(1):255-60.e1-2. PubMed ID: 19327767
[TBL] [Abstract][Full Text] [Related]
5. Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women.
Goodarzi MO; Shah NA; Antoine HJ; Pall M; Guo X; Azziz R
J Clin Endocrinol Metab; 2006 Oct; 91(10):4085-91. PubMed ID: 16849416
[TBL] [Abstract][Full Text] [Related]
6. First evidence of genetic association between AKT2 and polycystic ovary syndrome.
Goodarzi MO; Jones MR; Chen YD; Azziz R
Diabetes Care; 2008 Dec; 31(12):2284-7. PubMed ID: 18768676
[TBL] [Abstract][Full Text] [Related]
7. Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome.
Goodarzi MO; Jones MR; Antoine HJ; Pall M; Chen YD; Azziz R
J Clin Endocrinol Metab; 2008 Jan; 93(1):300-3. PubMed ID: 17940109
[TBL] [Abstract][Full Text] [Related]
8. Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene.
Jones MR; Mathur R; Cui J; Guo X; Azziz R; Goodarzi MO
J Clin Endocrinol Metab; 2009 Dec; 94(12):5034-8. PubMed ID: 19837928
[TBL] [Abstract][Full Text] [Related]
9. Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome.
Goodarzi MO; Louwers YV; Taylor KD; Jones MR; Cui J; Kwon S; Chen YD; Guo X; Stolk L; Uitterlinden AG; Laven JS; Azziz R
Fertil Steril; 2011 Apr; 95(5):1736-41.e1-11. PubMed ID: 21300347
[TBL] [Abstract][Full Text] [Related]
10. Role of luteinizing hormone β-subunit gene variants among South Indian women with polycystic ovary syndrome.
Dasgupta S; Sirisha PV; Neelaveni K; Anuradha K; Sudhakar G; Reddy BM
Gene; 2012 Feb; 494(1):51-6. PubMed ID: 22209983
[TBL] [Abstract][Full Text] [Related]
11. Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome.
Goodarzi MO; Xu N; Azziz R
J Clin Endocrinol Metab; 2008 Jul; 93(7):2909-12. PubMed ID: 18445661
[TBL] [Abstract][Full Text] [Related]
12. Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome.
Shah NA; Antoine HJ; Pall M; Taylor KD; Azziz R; Goodarzi MO
J Clin Endocrinol Metab; 2008 May; 93(5):1939-45. PubMed ID: 18303071
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature.
Cui L; Li G; Zhong W; Bian Y; Su S; Sheng Y; Shi Y; Wei D; Zhang W; Zhao H; Chen ZJ
Hum Reprod; 2015 Mar; 30(3):732-6. PubMed ID: 25586784
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor and binding protein polymorphisms in women with polycystic ovary syndrome: a case control study.
Song DK; Lee H; Hong YS; Sung YA
BMC Endocr Disord; 2019 Dec; 19(1):145. PubMed ID: 31870342
[TBL] [Abstract][Full Text] [Related]
15. The role of genetic variation in the lamin a/c gene in the etiology of polycystic ovary syndrome.
Urbanek M; Nampiaparampil G; D'Souza J; Sefton E; Ackerman C; Legro RS; Dunaif A
J Clin Endocrinol Metab; 2009 Jul; 94(7):2665-9. PubMed ID: 19401371
[TBL] [Abstract][Full Text] [Related]
16. A novel polymorphism in protein kinase AMP-activated catalytic subunit alpha 2 (PRKAA2) is associated with type 2 diabetes in the Han Chinese population.
Shen JZ; Ge WH; Fang Y; Liu H
J Diabetes; 2017 Jun; 9(6):606-612. PubMed ID: 27427333
[TBL] [Abstract][Full Text] [Related]
17. Circulating leptin concentration, LEP gene variants and haplotypes, and polycystic ovary syndrome in Bahraini and Tunisian Arab women.
Dallel M; Sghaier I; Finan RR; Douma Z; Hachani F; Letaifa DB; Mahjoub T; Almawi WY
Gene; 2019 Apr; 694():19-25. PubMed ID: 30721746
[TBL] [Abstract][Full Text] [Related]
18. Role of AMP-activated protein kinase gamma 3 genetic variability in glucose and lipid metabolism in non-diabetic whites.
Weyrich P; Machicao F; Staiger H; Simon P; Thamer C; Machann J; Schick F; Guirguis A; Fritsche A; Stefan N; Häring HU
Diabetologia; 2007 Oct; 50(10):2097-106. PubMed ID: 17701023
[TBL] [Abstract][Full Text] [Related]
19. Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage.
Chua AK; Azziz R; Goodarzi MO
Mol Hum Reprod; 2012 Jun; 18(6):320-4. PubMed ID: 22238371
[TBL] [Abstract][Full Text] [Related]
20. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
Deswal R; Nanda S; Dang AS
Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
